HIMS STOCK ANALYSIS

Hims Hers Health Inc — price, returns and risk statistics

HIMSHims Hers Health Inc

🇺🇸 USA · NYSE · Healthcare · Drug Manufacturers - Specialty & Generic

Value itDuel

Price summary

Last Close

36.80 $

Jul 2, 26

Market Cap

8.4 B $

Q1 2026 (TTM)

52-Week Range

14.52 $66.18 $

Return and risk cards

Total Return

%-22.5

Trailing 1-year performance

Volatility

%90.7

Price fluctuation measure

Sharpe Ratio

-0.29

Risk/Return ratio

Sortino Ratio

-0.34

Downside risk/return

Distance to Peak

%-44.4

Difference from 52-week peak

Maximum Drawdown

-%78.1

Deepest 1-year decline

Seasonality

Seasonality Chart

Year 2023
Year 2024
Year 2025
Current Period 2026
3/3 positive months

Periodic Returns

1M

+33.8%

3M

+92.3%

6M

+13.3%

YTD

+13.3%

1Y

-22.5%

3Y

+304.0%

Returns are computed from split-adjusted closes; dividends are not included.

YTD Return — Stock vs Asset Classes

Year-to-date
HIMS+13.3%Gold-3.2%Silver-10.4%S&P 500+9.3%

Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.

Monthly positivity

Monthly Avg Positive/Negative Close

Positive Count
Negative Count
Average Positive %
Average Negative %

Frequently Asked Questions

What is the current Hims Hers Health Inc (HIMS) stock price?

HIMS last closed at 36.80 $ (Jul 2, 26). Price data is refreshed after every trading day.

What is the market capitalization of Hims Hers Health Inc?

Hims Hers Health Inc (HIMS) has a market capitalization of approximately 8.4 B $ as of the latest reported period.

Who are the main competitors of HIMS?

Key peers of Hims Hers Health Inc include Laboratorios Farmaceuticos ROVI, Bausch Health Companies Inc, EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., Merck KGaA, Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi. A detailed metric comparison is available on the Peers tab.

Go deeper on HIMS

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.